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Introduction  
H.1 This chapter presents results for the Health domain of the latest wave of the 
English Longitudinal Study of Ageing (ELSA). Results are presented according to six 
domains of health: general health, diagnosed health conditions, sensory function, 
physical and functional capability, cognitive function and health behaviours. As this 
wave also includes a nurse visit, we also present tables on anthropometric measures, 
physical function tests and blood biomarkers. Where possible, results are presented as 
follows. 
• Cross-sectional tables (H1a to H8b) based on core members respondents of wave 
8 (including the refreshment sample members added in 2006–07, 2008–09, 2012–
13 and 2014–15). Results are classified by age (divided into five-year categories) 
and gender, and by gender and wealth groups (quintiles). Results are weighted for 
non-response using cross-sectional weight. 
• Longitudinal tables (HL1a to HL11b), based on a balanced ELSA sample of core 
members who participated in all waves (waves 4 to 8). Results are classified by 
age (divided into five-year categories) and gender at wave 4, and by gender and 
wealth groups (quintiles) at wave 4. Results are weighted using longitudinal 
weight. 
• Nurse visit cross-sectional tables (N1a to N9b) based on core sample member 
respondents of wave 8 (including the refreshment sample members added in 
2006–07, 2008–09, 2012–13 and 2014–15) who then consented to the nurse visit. 
Results are shown by age (divided into six-year categories) and gender, and by 
wealth groups (quintiles) and gender. Results are weighted for non-response using 
two cross-sectional weights. Anthropometric and physical functioning measures 
are weighted by nurse visit weights, while blood samples results are weighted by 
blood sampling weights. Note that a number of modules included at previous 
ELSA nurse waves have been omitted at wave 8, including standing height, waist 
and hip circumference measurement, lung function, balance, leg rise, chair rise 
and hair sample. In addition, the weight module was moved from the nurse to the 
interviewer questionnaire at wave 8. 
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Cross-sectional tables 
General health 
H.2 Table H1a shows the percentage of self-rated health categories (from excellent 
to poor) by age and gender at wave 8. The prevalence of women reporting excellent 
self-rated health decreases with age and reaches the lowest value at the age of 80 and 
above. However, for men, the lowest value is reported at the 75–79 age group. 
Overall, 73% of men and 72% of women report excellent, very good or good health. 
H.3 Table H1b shows the percentage of self-rated health by gender and wealth at 
wave 8. There is a steep economic gradient in self-rated health: men and women in 
the lowest wealth groups report more frequently fair or poor health than those in the 
highest wealth groups. Among the highest wealth group, 87% of men and 86% 
women rate their health good to excellent; the corresponding figures for men and 
women in the lowest wealth group are 50% and 54%, respectively. 
H.4 Table H2a shows the percentage of people reporting a long-standing limiting 
illness by age and gender at wave 8. The prevalence of men and women reporting a 
limiting long-standing illness increases with age, from 20% in men and 26% in 
women aged 55–59 to 55% in men and 57% in women aged 80 and above. 
H.5 Table H2b shows the percentage of limiting long-standing illness by gender 
and wealth at wave 8. The prevalence of men and women in the lowest wealth group 
reporting a long-standing limiting illness is over 50%, which is more than twice the 
proportion of those in the highest wealth group. 
Health conditions 
H.6 Table H3a shows the percentage of diagnosed health conditions by age and 
gender at wave 8. The same trends were observed for men and women. Overall, the 
prevalence of health conditions increases with age, except for cancer and respiratory 
illness, for which prevalence peaks at age 75–79 and lowers for people aged 80 and 
above, and for depression, which lowers after the age of 70. At all age groups, more 
men than women report coronary heart disease (CHD), while more women than men 
report arthritis and depression. Overall, the prevalence of chronic disease, particularly 
for arthritis and respiratory illnesses, is high in wave 8 of ELSA. 
H.7 Table H3b shows the percentage of health conditions by gender and wealth at 
wave 8. The prevalence of all health conditions is lowest in the highest wealth group 
for both men and women. The prevalence of CHD, diabetes, depression and 
respiratory illnesses is approximately double in the lowest wealth group than in the 
highest for men, and four times higher for women. For cancer, the trend is less 
marked for men and, for women, prevalence is relatively stable across all wealth 
groups. 
Sensory impairments 
H.8 Table H4a shows the percentage of self-rated sensory impairments (eyesight, 
hearing, smell and taste) by age and gender at wave 8. Hearing impairment is highly 
prevalent overall (28% of men and 19% of women) and increases steadily with age 
from 60 onwards to reach 43% of men and 37% of women aged 80 and above. A 
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similar trend of increase with age is observed for impairment in other senses, with the 
increase starting from age 65 for men and age 60 for women. In each age group, more 
men than women reported smell impairment, while more women report eyesight 
impairments than men. The lowest prevalence is for the taste impairment in both men 
and women (8% of men and 7% of women across all age groups). 
H.9 Table H4b shows the percentage of self-rated sensory impairments by gender 
and wealth at wave 8. Both men and women in the lowest wealth group report higher 
sensory impairments in each of the eyesight, hearing, smell and taste functions than 
those in the highest wealth group. 
Physical and functional capability 
H.10 Table H5a shows the mean walking speed (m/s) by age and gender at wave 8. 
The mean walking speed decreases with age for both men and women and is lower in 
women than men within each age group. The largest difference between women (0.63 
m/s) and men (0.72 m/s) is observed in the oldest age group. 
H.11 Table H5b shows the mean walking speed (m/s) by gender and wealth at wave 
8. The mean walking speed of men and women in the lowest wealth group is, on 
average, 0.25 m/s lower than that of people in the highest wealth group. 
H.12 Table H6a reports the prevalence of limitations with one or more activities of 
daily living (ADLs) and instrumental activities of daily living (IADLs) by age and 
gender at wave 8. The prevalence of men and women reporting limitations with one or 
more ADLs and IADLs increases with age. At all ages, women are more likely to 
report difficulties with ADLs and IADLs than men. 
H.13 Table H6b reports the prevalence of limitations with one or more ADLs and 
IADLs by gender and wealth at wave 8. There is a strong socio-economic gradient, 
with more than three times the proportion of men and women having limitations with 
one or more ADLs and IADLs in the lowest wealth group compared with the highest 
wealth group. In the lowest wealth groups, there is a gender difference in the 
prevalence of those reporting limitations with one or more ADLs (with higher 
prevalence in women than men), which is relatively attenuated in the highest quintiles 
of wealth. There are no significant gender differences in the prevalence of reporting 
limitations with one or more IADLs within each wealth group. 
Cognitive function 
H.14 Table H7a reports the mean cognitive performance on memory, attention and 
comprehension by age and gender at wave 8. Memory declines with age in both men 
and women, although the scores are slightly higher for women than men within each 
age group. A slight decline in attention capability is observed for men by age, while 
for women there is a stable performance in attention across the age groups. 
Comprehension decreases a little at older ages for both men and women. 
H.15 Table H7b reports the mean cognitive function by gender and wealth at wave 
8. In both men and women, all aspects of cognitive functioning – memory, attention 
and comprehension – are lowest in the lowest wealth group. 
Health behaviours 
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H.16 Table H8a shows the prevalence of several health behaviours (smoking, 
physical activity, alcohol consumption and fruit and vegetable consumption) by age 
and gender at wave 8. In both men and women, the prevalence of current smokers 
decreases with age, while the prevalence of those being physically inactive increases 
with age. The peak prevalence of men and women reporting daily alcohol 
consumption is between the ages 70 and 74, and alcohol consumption is slightly lower 
at older ages. The highest prevalence of consuming five or more portions of fruit and 
vegetables a day is found for men and women aged 65–79. 
H.17 Table H8b shows the prevalence of several health behaviours by gender and 
wealth at wave 8. In both men and women, the prevalence of current smokers and 
physical inactivity is highest in the lowest wealth groups. The prevalence of daily 
alcohol intake and consumption of five or more portions of fruit and vegetables is 
lowest in the lowest wealth group. Over a third of men and women in the lowest 
wealth group are physically inactive, and close to half eat fewer than five portions of 
fruit and vegetables a day. 
Longitudinal tables 
H.18 Cross-sectional tables using a series of data from different time periods 
combine the effect of age, time and differential mortality. For example, looking at 
cross-sectional data on income over time, it would not be possible to isolate the effect 
of age on income because the effect of time or differential mortality cannot be 
completely stripped out (i.e. the observation that higher-income individuals tend to 
live longer than lower-income individuals). Because longitudinal data follow the same 
individuals over time, by selecting a sample of individuals who are interviewed at 
every wave, we can eliminate the effect of differential mortality. The tables that 
follow take the set of individuals who have responded at every wave from waves 4 to 
8 (the ‘balanced panel’) and track some health conditions by age, gender and wealth 
in 2008–09 (the ‘baseline’ years) across waves over eight years follow-up. 
General health 
H.19 Table HL1a shows the percentage of participants reporting fair or poor self-
rated health by age and gender for waves 4 to 8. The prevalence of men and women 
reporting fair or poor health increases from wave 4 to wave 7, particularly in the older 
age group. 
H.20 Table HL1b shows the percentage of participants reporting fair or poor self-
rated health by gender and wealth for waves 4 to 8. The prevalence of men and 
women reporting fair or poor health is consistently higher for both men and women in 
the lowest wealth groups compared with the highest wealth groups. The increase 
across waves is, therefore, less steady in the lowest wealth groups, as the initial 
percentages are higher than in the highest wealth group, where the proportion more 
than doubles over time.  
Health conditions 
H.21 Tables HL2a and HL3a show the percentage of CHD and diabetes by age and 
gender for waves 4 to 8. The percentage of men and women reporting CHD and 
diabetes doubles from wave 4 to wave 8, particularly for older individuals.  
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H.22 Tables HL2b and HL3b show the percentage of CHD and diabetes by gender 
and wealth for waves 4 to 8. The percentage of men and women reporting CHD and 
diabetes is highest at every wave among individuals in the lowest wealth group. 
H.23 Table HL4a shows the percentage of cancer by age and gender for waves 4 to 
8. Overall, the prevalence of cancer increases from wave 4 to 8 and in all age groups, 
and is higher in women than men. However, trends are different according to age: 
women aged between 50 and 64 at baseline show a higher prevalence of cancer than 
men (of the same age) at every wave. It is likely that a survival effect is occurring for 
men aged 75–79 and for women aged 70–79 at baseline (wave 4) for whom we see a 
particularly low prevalence of cancer at wave 4. 
H.24 Table HL4b shows the percentage of cancer by gender and wealth for waves 4 
to 8. There is no marked difference in the prevalence of cancer among wealth groups. 
H.25 Table HL5a reports the prevalence of diagnosed depression by age and gender 
in waves 4 to 8. The percentage of men and women reporting depression increases 
significantly from wave 4 to wave 8, and at each wave is higher in women than in 
men. Older men and women show consistently lower percentages of diagnosed 
depression than younger men and women. 
H.26 Table HL5b reports the prevalence of diagnosed depression by gender and 
wealth in waves 4 to 8. Men and women in the highest wealth groups are less likely to 
be depressed, and this holds across waves. 
Physical and functional capability 
H.27 Table HL6a reports the mean walking speed by age and gender for waves 4 to 
8. For both men and women, mean walking speed decreases from wave 4 to wave 8 in 
each age group, and the decline is steeper from the age of 70 onwards for women and 
from 75 onwards for men. At every wave, walking speed decreases with increasing 
age. 
H.28 Table HL6b reports the mean walking speed by gender and wealth for waves 4 
to 8. For both men and women, walking speed is consistently higher in the highest 
wealth groups. 
H.29 Table HL7a reports the prevalence of participants reporting limitations with 
one or more ADLs by age and gender for waves 4 to 8. In both genders, the 
prevalence of those reporting limitations with one or more ADLs increases over time, 
particularly for people aged 60 and above. There is also a clear gradient by age at 
every wave for both men and women. 
H.30 Table HL7b reports the prevalence of participants reporting limitations with 
one or more ADLs by gender and wealth for waves 4 to 8. In both genders, the 
prevalence of those reporting limitations with one or more ADLs is consistently 
higher by almost three times in the lowest wealth group compared with the highest 
wealth group at every wave for both men and women. 
Cognitive function 
H.31 Table HL8a reports the mean cognitive performance in memory by age and 
gender at waves 4 to 8. In men, the overall memory function score is almost constant 
over time, while for women there is a slight decrease from wave 4 to wave 8. No 
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decline is observed in men and women aged 50–59 at baseline, while a steeper decline 
is observed in the older age groups 75 and above.  
H.32 Table HL8b reports the mean cognitive performance in memory by gender and 
wealth at waves 4 to 8. For both men and women, the decrease in memory over time 
is more pronounced in the lowest wealth group. 
Health behaviours 
H.33 Table HL9a shows the prevalence of cigarette smoking by age and gender for 
waves 4 to 8. There is an overall linear decrease in the prevalence of smoking over 
time for both men and women.  
H.34 Table HL9b shows the prevalence of smoking by gender and wealth for waves 
4 to 8. In both genders, the proportion of smokers is much higher in the lowest wealth 
groups compared with highest wealth groups, and the prevalence of current smokers 
decreases over time in all wealth groups from wave 4 onwards. 
H.35 Table HL10a shows the percentage of daily alcohol consumers by age and 
gender for waves 4 to 8. Overall, the percentage of alcohol consumers decreases over 
time, particularly from wave 4 to wave 7, and then increases slightly in wave 8. This 
trend is observed in most age groups. 
H.36 Table HL10b shows the percentage of daily alcohol consumers by gender and 
wealth for waves 4 to 8. The proportion of daily alcohol consumers is much higher in 
the highest wealth groups compared with the lowest: twice as much in men and three 
times as much in women.  
H.37 Table HL11a shows the prevalence of physical inactivity by age and gender 
for waves 4 to 8. In both genders, the percentage of those physically inactive increases 
over time in all the age groups, except the youngest age group 50–54, for whom the 
prevalence of physical inactivity remains approximately stable from wave 5 to wave 
8. 
H.38 Table HL11b shows the prevalence of physical inactivity by gender and 
wealth for waves 4 to 8. Physical inactivity increases over time in all wealth groups. 
At each wave, the proportion of participants reporting physical inactivity is three to 
five times higher in the lowest wealth group compared with the highest wealth group. 
Nurse visit cross-sectional tables 
Anthropometry 
H.39 Tables N1a and N1b show the means and body mass index (BMI) categories 
by gender and age category at wave 8. The overall mean BMI in 2016–17 is similar 
for men (28.3 kg/m2) and women (28.2 kg/m2). Among men, mean BMI starts 
decreasing after the ages 65–69 from 29.2 to 27.2 kg/m2 for those aged 80 and above. 
In women, mean BMI also decreases after ages 65–69 from 28.8 to 26.7 kg/m2 for 
those aged 80 and above. Less than 1% of men and women are underweight. A third 
of women and just over a fifth of men have BMI in the desirable category. More men 
(46.5%) than women (33.5%) are overweight, and this applies to all age groups, but 
more women (33.7%) than men (30.7%) are obese. The very oldest groups are the 
least likely to be obese. 
H.40 Tables N1c and N1d show mean BMI and BMI categories by wealth group 
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and gender. The prevalence of elevated BMI and obesity is lower in the richest 
wealth groups.  
Blood pressure 
H.41 Table N2a shows mean systolic (SBP) and mean diastolic (DBP) blood 
pressure by age category and gender. SBP and DBP are higher among men than 
women. Among men, SBP increases until age 79 and then there is a small decrease, 
while among women there appears to be a steady increase in SBP with age. Among 
both men and women, increased age is associated with decreases in DBP.  
H.42 Table N2b shows mean SBP and DBP by wealth category and gender. Mean 
levels of SBP and DBP do not show a clear pattern of association with wealth.  
Lipid profile 
H.43 Table N3a shows mean levels of total cholesterol, high density lipoprotein 
(HDL) cholesterol, low density lipoprotein (LDL) cholesterol and triglycerides by 
age category and gender. For each of these, the proportion of individuals reporting 
‘at-risk’ values is also reported.  
At every age, men have lower levels of total cholesterol than women, and among 
men, these levels decrease with age. Among women, there is a small decrease in the 
mean cholesterol levels with age. Overall, 45.6% of men and 66% of women have 
high total cholesterol levels (greater than 5.0 mmol/l). The gender difference in raised 
total cholesterol is more pronounced in the older groups because the percentage with 
higher cholesterol declines sharply with age for men but more gradually for women.  
Mean HDL cholesterol is higher for women than for men in every age category. 
Overall, mean HDL cholesterol levels do not vary appreciably with age in either 
gender. There are 11% of men and 8.8% of women who have ‘high risk’ levels of 
HDL (lower than 1.0 mmol/l for men and less than 1.2 mmol/l for women), and no 
consistent pattern of difference with age is seen in either gender.  
The mean LDL cholesterol levels are slightly lower in men (2.94 mmol/l) than in 
women (3.19 mmol/l). In men, LDL cholesterol concentrations decrease with age, 
while there is little variation with age for women. In total, 60.8% of men and 68.2% 
of women have elevated levels of LDL cholesterol (greater than 3.0 mmol/l). The 
prevalence of high LDL levels in men decreases with age (e.g. 56% of men aged 50–
54 compared with 37% of men aged 75–79). In women, the prevalence of high LDL 
also decreases with age. Mean triglycerides concentrations are 1.20 mmol/l in women 
and 1.34 mmol/l in men. In men, there is a decrease in mean levels by age.  
There are 32% of men and 25% of women who have elevated levels of triglycerides 
(greater than 1.7 mmol/l). The prevalence of high levels of triglyceride decreases 
with greater age in men, while the trend is not so evident among women. Note that 
values for LDL and triglycerides are available only for participants who provided 
fasting blood samples. 
H.44 Table N3b shows lipid profile by wealth group and gender. Mean levels of 
total and LDL cholesterol show a marked socio-economic gradient that is the reverse 
of what might be expected. Increasing wealth is associated with higher levels of both 
total and LDL cholesterol. However, fewer participants who are in the highest wealth 
group have low levels of ‘good’ cholesterol (HDL) that would indicate increased 
risk. Similarly, levels of triglycerides decrease with increasing wealth. 
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Inflammatory markers  
H.45 Table N4a shows mean concentration levels of inflammatory markers 
fibrinogen (g/l) and C-reactive protein (CRP) concentrations (mg/l) by age category 
for men and women. The mean levels of fibrinogen and CRP increase with age in 
both men and women. 
H.46 Table N4b shows mean levels of fibrinogen and CRP by wealth group and 
gender. With increasing wealth, both fibrinogen and CRP levels decrease.  
Glycated haemoglobin 
H.47 Table N5a shows the mean glycated haemoglobin (HbA1c) levels by age and 
gender. There is a small increase with age in both men and women.  
H.48 Table N5b shows levels of glycated haemoglobin by wealth category and 
gender. Glycated haemoglobin is inversely related to wealth such that wealthier 
participants have lower levels of HbA1c.  
Haemoglobin 
H.49 Table N6a shows mean haemoglobin levels and the proportion of individuals 
who are classified as anaemic (haemoglobin below 13g/dl for men and below 12 g/dl 
for women) by age category and gender. Mean levels of haemoglobin are higher in 
men than women. For both genders, there is a decrease in levels with age. Overall, 
8.5% of men and 9.2% of women have low haemoglobin (anaemia). In both men and 
women, there is a clear upward shift in the prevalence of anaemia at the oldest age 
groups. In men, the prevalence of anaemia increases from 1% in the youngest age 
group to 28% in the oldest age group, with substantial differences between those 
aged 75 and above and those who were younger. Women show a similar pattern. 
H.50 Table N6b shows mean levels of haemoglobin and the percentage of 
participants with anaemia in wave 8 by wealth group and gender. While mean 
haemoglobin levels do not differ appreciably by wealth group, the prevalence of 
anaemia is lower among participants in the highest wealth group. 
Insulin-like growth factor-1  
H.51 Table N7a shows the mean levels of insulin-like growth factor-1 (IGF-1) by 
age category and gender. Overall, mean levels decrease with age. The prevalence of 
those in the lowest quintile of levels of IGF-1 increases considerably with age in both 
men (from just 10.8% at 55–59 age group to 48.7% at 80 and above) and women 
(from 16.7% at 50–54 age group to 42.4% at 80 and above). 
H.52 Table N7b shows mean levels of IGF-1 by wealth group and gender. A socio-
economic gradient is evident, with increases in mean levels and decreases in the 
proportion of those in the lowest quintile with increased wealth.  
Vitamin D 
H.53 Table N8a shows the mean levels of Vitamin D by age category and gender. 
Overall, the mean levels of Vitamin D are similar for both men and women. There 
also does not appear to be a consistent pattern of change with age.  
H.54 Table N8b shows mean levels of Vitamin D by wealth group and gender. A 
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socio-economic gradient is observed, with increases in levels with increased wealth.  
Grip strength  
H.55 Table N9a shows mean grip strength by age category and gender. A marked 
gender difference in grip strength is seen, with men having much higher mean grip 
strength at every age. For both genders, there is a decrease in grip strength with 
increasing age.  
H.56 Table N9b shows mean grip strength by wealth group and gender. Wealthier 
participants have higher mean grip strength.  
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Annex AH. Definitions 
AH.1 Activities of daily living (ADLs) and instrumental activities of daily living 
(IADLs): Respondents were asked to report whether because of a physical, mental, 
emotional or memory problem they have any difficulty with ADLs (dressing, walking 
across a room, bathing or showering, eating, getting out of bed, using the toilet) and 
with IADLs (using a map, preparing a hot meal, shopping for groceries, making 
phone calls, taking medications, doing work around the house, managing money). 
From the responses to these questions, two variables were derived to indicate whether 
the respondent had difficulties with one or more ADLs and IADLs. 
AH.2 Age: Defined as age at last birthday 
AH.3 Alcohol consumption: Based on the questions concerning frequency of alcohol 
consumption, a variable was derived to indicate whether or not the respondent was 
drinking alcohol three days a week or more (which was then labelled as daily alcohol 
consumption). 
AH.4 Balanced panel: The set of individuals are who interviewed in all waves of 
interest. 
AH.5 Baseline: The wave of data that is chosen to be the starting point for 
characteristics in the longitudinal analysis that may change over time. 
AH.6 Cognitive function – attention: This is an index that combines the scores on 
the cognitive test on attention and calculation (counting backward and a set of 
subtractions). Higher scores indicate better attention and executive functioning. 
AH.7 Cognitive function – comprehension and naming: A score that combines the 
results of five questions (naming objects and people) relying on comprehension and 
semantic memory. Higher scores indicate better comprehension and naming 
capability. 
AH.8 Cognitive function – memory: This is an overall memory score that combines 
the scores on the two objective memory tests (immediate and delayed memory) using 
a 10-word list. The overall score ranges from 0 to 20. Higher scores indicate better 
memory. 
AH.9 Consumption of fruit and vegetables: Based on the questions regarding fruit and 
vegetable consumption, a variable was derived to indicate whether the respondent ate 
five or more portions of fruits and vegetables a day. 
AH.10 Health conditions: Respondents were asked whether a doctor had ever told 
them that they suffered from any of the following conditions: CHD (angina or 
myocardial infarction), diabetes, cancer, respiratory illness (asthma or pulmonary 
disease), arthritis and depression. 
AH.11 Limiting long-standing illness: Respondents were asked whether they suffered 
from any illness or disability that affected them over a long period and, if so, whether 
the illness limited their activities in some way. 
AH.12 Physical activity: Based on the questions regarding frequency of leisure-time 
physical activity, a variable was derived to indicate whether or not the respondent was 
physically inactive (sedentary physical activity). 
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AH.13 Self-rated hearing acuity: Respondents were asked to rate their hearing, as 
excellent, very good, good, fair or poor. Self-rated hearing impairment was defined as 
having declared a fair or poor hearing. 
AH.14 Self-rated sense of smell: Respondents were asked to rate their sense of smell 
as excellent, very good, good, fair or poor. Self-rated smell impairment was defined as 
having reported a fair or poor sense of smell. 
AH.15 Self-rated taste: Respondents were asked to rate their sense of taste, as 
excellent, very good, good, fair or poor. Self-rated taste impairment was defined as 
having declared a fair or poor sense of taste. 
AH.16 Self-rated general health: Respondents were asked to rate their health as 
excellent, very good, good, fair or poor. Because self-rated general health was 
collected at wave 3 using a different version, for comparability, the results from that 
wave are omitted from the tables. 
AH.17 Smoking status: Defined as whether the respondent was a current smoker or 
not. 
AH.18 Total non-pension wealth: Total non-pension wealth is reported at the family 
level and is defined as the sum of net financial wealth, net physical wealth and net 
housing wealth. 
AH.19 Walking speed: A walking speed test was performed among participants aged 
60 and above. The test involved timing how long it took to walk a distance of 8 feet. 
The total score indicates the walking speed of respondents in metres per second (m/s) 
with higher scores indicating faster speed. 
AH.20 Wealth groups: To form wealth groups, we order all ELSA sample members 
according to the value of their total (non-pension) family wealth, and we divide the 
sample into five equal-sized groups. Where analysis is carried out using all ELSA 
sample members, the groups are equal in size and can be referred to as quintiles. 
Much of the analysis in this chapter is carried out using subsamples of the ELSA 
population. Where analysis does not use the whole ELSA sample, the groups are 
unequal in size and are more accurately referred to as ‘wealth groups’. For 
consistency reasons, we use the term ‘wealth group’ rather than ‘wealth quintile’ 
throughout the chapter. The cut-off points for the wealth groups are shown in the 
following table, reported in January 2017 prices and rounded to the nearest £1,000. 
 Wealth group definition, 
wave 1 (2002–03) 
Wealth group definition, 
wave 4 (2008–09) 
Wealth group definition, 
wave 8 (2016–17) 
Lowest Less than £22k Less than £60k Less than £71k 
2nd  Between £22k and £132k Between £60k and £201k Between £71k and £210k 
3rd  Between £132k and £229k Between £201k and £303k Between £210k and £354k 
4th  Between £229k and £403k Between £303k and £496k Between £354k and £575k 
Highest More than £403k More than £496k More than £575k 
 
AH.21 Notes to all tables 
The unit of observation in all tables is the individual. 
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All cross-sectional tables are based on the cross-section of ELSA sample members in 
each wave of data. This includes refreshment sample members. 
All longitudinal tables are based on individuals who have responded in all of waves 4 
to 8 (the ‘balanced panel’) unless otherwise specified. 
All numbers are based on weighted data. Unweighted frequencies (N) are reported.  
For cross-sectional analyses, the figures are weighted for non-response. For 
longitudinal analyses, the figures are weighted for non-response and attrition from 
wave 4 to wave 8 using longitudinal weights. 
The fieldwork dates are shown in the following table. 
 Fieldwork dates (inclusive) 
Wave 1 March 2002 – March 2003 
Wave 2 June 2004 – June 2005 
Wave 3 May 2006 – August 2007 
Wave 4 June 2008 – July 2009 
Wave 5 July 2010 – June 2011 
Wave 6 May 2012 – May 2013 
Wave 7 June 2014 – May 2015 
Wave 8 May 2016 – June 2017 
 
AH.22 The nurse visit: All core members were eligible for a nurse visit in person (i.e. 
not by proxy) either in a private household or in an institution. A nurse visit was 
provided to only those partners who explicitly request a nurse visit. The CAPI 
(computer-assisted personal interview) programme was used. After the main 
interview, the interviewer made an appointment for the nurse to visit the respondent 
or set up contact between nurse and respondent. The nurse visit consisted of a series 
of measurements that were only obtained if the appropriate consents were obtained 
and the respondent was able to respond affirmatively to relevant safety questions. The 
nurse visit included several standard measures including: anthropometric measures, 
blood pressure, blood sample and lung function. Full information on all the 
measurements collected during the nurse visit can be found in the wave 8 technical 
report.  
AH.23 Height: Height was measured using a portable stadiometer with a sliding 
headplate, a base plate and three connecting rods marked with a metric scale. 
Respondents were asked to remove their shoes. One measurement was taken with the 
respondent stretching to the maximum height and the head in the Frankfort plane.51 
The reading was recorded to the nearest millimetre. 
AH.24  Weight: Weight was measured using a portable electronic scale. Respondents 
were asked to remove their shoes and any bulky clothing. A single measurement was 
recorded to the nearest 0.1 kg. Respondents who weighed more than 130 kg were 
asked for their estimated weights because the scales are inaccurate above this level. 
These estimated weights were included in the analysis.  
                                                 
51 The Frankfort plane is an imaginary line passing through the external ear canal and across the top of 
the lower bone of the eye socket, immediately under the eye. This line must be parallel with the floor. 
This gives the maximum vertical distance from the floor to the highest point of the skull. 
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AH.25 Body mass index (BMI): BMI is a widely accepted measure of weight for 
height and is defined as weight in kilograms divided by the square of the height in 
metres (kg/m2). BMI was calculated for all those respondents for whom both a valid 
height and weight measurement were recorded. We categorised the BMI scores into 
four main groups:  
• underweight group (<18.5 kg/m2);  
• normal (≥18.5 and <25 kg/m2);  
• overweight (≥25 and <30 kg/m2); 
• obese (≥30 kg/m2). 
AH.26 Blood pressure: All respondents were eligible for the blood pressure module, 
except those who were pregnant. Three readings were collected at one-minute 
intervals (systolic, diastolic and pulse rate) using the Omron HEM-907 equipment. It 
was ensured that the room temperature was between 15°C and 25°C. The respondent 
was asked not to eat, smoke, drink alcohol or take vigorous exercise in the 30 minutes 
preceding the blood pressure measurement as blood pressure can be raised 
immediately after any of these activities. Systolic (SBP) and diastolic (DBP) blood 
pressure was measured using a standardised method. In adults, hypertension is defined 
as a SBP of at least 140 mmHg or a DBP of at least 90 mmHg or being on medication 
to control hypertension. The systolic arterial pressure is defined as the peak pressure 
in the arteries, which occurs near the beginning of the cardiac cycle. The diastolic 
arterial pressure is the lowest pressure at the resting phase of the cardiac cycle. 
AH27. Blood sample: Blood samples were taken from willing ELSA core members, 
except those who had a clotting or bleeding disorder (e.g. haemophilia and low 
platelets), had ever had a fit, were not willing to give their consent in writing, were 
currently on anticoagulant drugs (e.g. warfarin therapy). Fasting blood samples were 
taken whenever possible. However, respondents aged over 80, those known to be 
diabetic and on treatment, those who had a clotting or bleeding disorder or were on 
anti-coagulant drugs (e.g. warfarin), those who had ever had fits and those who 
seemed frail, or the nurse was concerned about their health, were not asked to fast. 
Subjects were considered to have fasted if they had not had food or drink except water 
for a minimum of five hours prior to the blood test. The amount of blood taken from 
each participant in order to analyse each biomarker is presented below: 
• one citrate blue tube (1.8 ml) – fibrinogen;  
• one plain red tube (6 ml) – total and HDL cholesterol, triglycerides, ferritin, C-
reactive protein (CRP), IGF-1 and DHEAS; 
• one fluoride grey tube (2 ml) – fasting glucose; 
• one EDTA light purple tube (2 ml) – haemoglobin and glycated haemoglobin; 
• two EDTA dark purple tube (4 ml) – genetics. 
All the blood samples were analysed at the Royal Victoria Infirmary laboratory in 
Newcastle.  
Blood analytes  
These are the blood analytes measured. 
• Total cholesterol: cholesterol is a type of fat present in the blood, related to diet. 
Too much cholesterol in the blood increases the risk of heart disease.  
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• High density lipoprotein (HDL) cholesterol: this is ‘good’ cholesterol, which is 
protective for heart disease. 
• Low density lipoprotein (LDL) cholesterol: this is the ‘bad’ cholesterol and a risk 
factor for cardiovascular disease. 
• Triglycerides: together with total and HDL cholesterol, they provide a lipid profile 
that can give information on the risk of cardiovascular disease. Measures of LDL 
and triglycerides were only taken for participants who were asked to fast. 
• Fibrinogen: a protein necessary for blood clotting. High levels are also associated 
with a higher risk of heart disease. 
• C-reactive protein: the level of this protein in the blood gives information on 
inflammatory activity in the body, and it is also associated with risk of heart 
disease. 
• Glycated haemoglobin: this indicates the presence or risk of type 2 diabetes, 
which is associated with an increased risk of heart disease.  
• Haemoglobin: these are measures of iron levels in the body and are related to diet 
and other factors. Anaemia is defined as having a haemoglobin level below 13 
g/dl for men and below 12 g/dl for women. 
• Insulin-like growth factor 1 (IGF-1): this is a hormone that helps to control 
reactions to stress and to regulate various body processes including digestion, the 
immune system, mood and energy usage. 
• Vitamin D: this is a steroid vitamin, which promotes the intestinal absorption and 
metabolism of calcium and phosphorus. Under normal conditions of sunlight 
exposure, no dietary supplementation is necessary because sunlight promotes 
adequate vitamin D synthesis in the skin. Deficiency can lead to bone deformity 
(rickets) in children and bone weakness in adults. Vitamin D comes from the diet 
(eggs, fish and dairy products) and is produced in the skin. Skin production of the 
active form of vitamin D depends on exposure to sunlight. Active people living in 
sunny regions produce most of the vitamin D they need from their skin. In less 
sunny climes, the skin production of vitamin D is markedly diminished in the 
winter months, especially among the elderly and the housebound. In that 
population, vitamin D supplements become important.  
 
AH.28 Grip strength: The grip strength test is a measure of upper body strength. The 
test was given to all respondents who were willing to take it, with no upper or lower 
age limits. Participants were, however, excluded if they had swelling or inflammation, 
severe pain or a recent injury, or if they had had surgery to the hand in the preceding 
six months. If there was a problem with only one hand, measurements were taken 
using the other hand. After adjusting the gripometer (grip gauge) to suit the 
respondent’s hand and positioning the respondent correctly, the respondent was asked 
to squeeze the gripometer as hard as they could for a couple of seconds. Three values 
were recorded for each hand, starting with the non-dominant hand and alternating 
between hands. Any measurements carried out incorrectly were not included. The 
gripometer used was the ‘Smedley’s for Hand’ Dynamo Meter, with a scale ranging 
from 0 to 100 kg. The average of three measurements (in kilograms) is reported here.  
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Table H1a. Self-rated health (%), by age group and gender: wave 8 
  Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
Excellent 17.1 15.7 13.6 8.8 5.9 6.9 12.4 
Very good 35.1 31.9 32.5 26.5 19.9 20.9 29.2 
Good 29.2 27.2 30.6 35.2 36.9 31.8 31.2 
Fair 13.7 14.4 15.7 20.3 25.1 30.4 18.6 
Poor 4.9 10.9 7.6 9.1 12.2 10.1 8.6 
Women        
Excellent 19.5 14.7 11.3 9.0 5.9 4.6 11.5 
Very good 31.6 31.2 29.6 29.5 23.1 19.8 27.9 
Good 28.1 31.5 35.2 31.3 38.2 34.4 32.7 
Fair 13.5 15.8 16.6 20.5 23.7 27.7 19.1 
Poor 7.2 6.8 7.3 9.7 9.1 13.5 8.8 
        
Unweighted N        
Men 226 551 635 603 435 471 2,921 
Women 307 711 869 664 518 697 3,766 
For variable definitions, see AH.2, AH.16 and AH.21. For related text, see H.2 
 
Table H1b. Self-rated health (%), by gender and wealth group: wave 8 
  Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men      
Excellent 5.6 10.9 10.9 13.1 18.5 
Very good 14.7 22.4 31.0 33.8 39.7 
Good 29.9 32.6 32.7 32.9 28.4 
Fair 26.0 24.5 18.2 16.2 10.9 
Poor 23.9 9.6 7.2 4.0 2.5 
Women      
Excellent 4.7 9.3 10.7 12.9 20.6 
Very good 14.4 22.1 30.0 38.2 34.6 
Good 34.9 34.4 32.1 30.7 31.2 
Fair 26.8 21.2 20.3 14.7 11.9 
Poor 19.2 12.9 6.9 3.5 1.7 
      
Unweighted N      
Men 429 489 595 655 710 
Women 656 764 789 744 741 
For variable definitions, see AH.16, AH.18, AH.20 and AH.21. For related text, see H.3. 
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Table H2a. Limiting long-standing illness (%), by age group and gender: wave 8 
  Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men 19.9 28.1 30.4 35.7 44.6 55.2 33.3 
Women 25.5 31.5 34.3 38.5 43.7 56.5 37.5 
        
Unweighted N        
Men 231 576 659 624 458 516 3,064 
Women 316 726 888 680 535 759 3,904 
For variable definitions, see AH.2 and AH.11. For related text, see H.4. 
 
Table H2b. Limiting long-standing illness (%), by gender and wealth group: wave 8 
  Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men 55.0 38.7 30.8 28.4 19.8 
Women 55.3 44.1 34.3 29.5 24.0 
      
Unweighted N      
Men 455 519 621 678 733 
Women 680 786 804 765 768 
For variable definitions, see AH.11, AH.18, AH.20 and AH.21. For related text, see H.5. 
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Table H3a. Diagnosed health conditions (%), by age group and gender: wave 8 
  Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
CHD 3.9 11.0 14.5 23.0 24.6 31.6 16.1 
Diabetes 8.7 15.3 15.3 19.1 21.3 17.5 15.4 
Cancer 6.4 6.0 8.4 15.1 22.2 21.9 11.8 
Respiratory illness 12.5 17.0 17.1 23.2 23.9 18.7 17.9 
Arthritis 19.5 28.6 36.8 43.4 48.4 51.6 35.6 
Depression 9.8 13.6 11.9 10.5 7.3 5.0 10.1 
Women        
CHD 2.3 3.7 7.7 11.0 17.7 23.9 10.3 
Diabetes 9.5 10.7 12.2 15.1 14.3 18.3 13.1 
Cancer 8.1 12.2 13.4 17.8 16.7 17.3 13.8 
Respiratory illness 14.4 19.3 22.4 24.0 26.6 22.2 20.9 
Arthritis 30.3 44.5 55.7 60.2 63.6 70.2 52.5 
Depression 16.4 16.5 16.7 16.4 12.0 7.9 14.5 
        
Unweighted N        
Men        
CHD 231 575 658 624 457 516 3,061 
Diabetes 231 575 658 624 457 516 3,061 
Cancer 231 576 659 624 456 517 3,063 
Respiratory illness 231 576 659 624 459 517 3,066 
Arthritis 231 576 659 624 456 517 3,063 
Depression 231 576 659 624 459 517 3,066 
Women        
CHD 316 726 888 680 534 757 3,901 
Diabetes 316 726 888 680 534 757 3,901 
Cancer 316 726 888 679 535 759 3,903 
Respiratory illness 316 726 888 680 535 759 3,904 
Arthritis 316 726 888 679 535 759 3,903 
Depression 316 726 888 680 535 759 3,904 
For variable definitions, see AH.2, AH.10 and AH.21. For related text, see H.6. 
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Table H3b. Diagnosed health conditions (%), by gender and wealth group: wave 8 
  Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men      
CHD 25.8 15.2 19.6 13.8 9.6 
Diabetes 23.4 16.4 13.6 14.4 11.3 
Cancer 14.2 12.9 11.7 11.7 9.5 
Respiratory illness 25.9 19.1 18.2 15.8 13.5 
Arthritis 46.8 38.1 37.5 34.7 25.3 
Depression 17.5 12.2 7.5 8.8 6.3 
Women      
CHD 17.4 13.9 8.9 6.9 3.9 
Diabetes 20.9 15.6 12.9 8.6 7.5 
Cancer 14.6 11.5 14.8 12.7 14.9 
Respiratory illness 30.9 21.1 20.6 16.9 15.0 
Arthritis 66.2 56.8 51.9 46.4 42.2 
Depression 19.9 15.3 15.3 12.0 10.1 
      
Unweighted N     
Men      
CHD 455 519 619 678 733 
Diabetes 455 519 619 678 733 
Cancer 454 519 622 678 732 
Respiratory illness 455 519 622 678 734 
Arthritis 454 519 622 678 732 
Depression 455 519 622 678 734 
Women      
CHD 679 785 804 765 768 
Diabetes 679 785 804 765 768 
Cancer 680 786 804 765 767 
Respiratory illness 680 786 804 765 768 
Arthritis 680 786 804 765 767 
Depression 680 786 804 765 768 
For variable definitions, see AH.10, AH.18, AH.20 and AH.21. For related text, see H.7. 
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Table H4a. Self-rated sensory impairment (%), by age group and gender: wave 8 
  
  
Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
Eyesight impairment 7.5 10.1 8.3 10.4 17.7 24.1 11.9 
Hearing impairment 21.8 20.2 24.1 32.5 34.3 42.6 27.7 
Smell impairment 11.1 16.7 15.5 20.0 21.1 23.2 17.0 
Taste impairment 5.2 6.4 5.9 9.2 11.0 11.6 7.6 
Women        
Eyesight impairment 10.3 9.9 12.1 15.1 15.5 28.3 14.9 
Hearing impairment 12.8 12.3 14.9 17.2 22.7 37.4 19.0 
Smell impairment 9.4 10.0 9.8 11.9 12.5 16.4 11.5 
Taste impairment 5.7 5.6 6.0 7.2 7.3 11.2 7.0 
        
Unweighted N        
Men        
Eyesight impairment 231 574 659 624 458 517 3,063 
Hearing impairment 231 575 659 624 458 517 3,064 
Smell impairment 226 549 635 603 435 472 2,920 
Taste impairment 226 550 635 603 435 472 2,921 
Women        
Eyesight impairment 316 725 888 680 535 758 3,902 
Hearing impairment 316 725 888 680 535 759 3,903 
Smell impairment 307 711 869 664 518 696 3,765 
Taste impairment 307 711 869 664 518 696 3,765 
For variable definitions, see AH.2, AH.13–AH.15 and AH.21. For related text, see H.8. 
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Table H4b. Self-rated sensory impairment (%), by gender and wealth group: wave 8 
  
  
Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men      
Eyesight impairment 24.2 12.9 9.7 9.4 6.5 
Hearing impairment 32.9 32.1 29.5 27.3 19.4 
Smell impairment 17.4 19.1 19.3 15.6 14.7 
Taste impairment 11.4 8.3 7.2 6.2 5.9 
Women      
Eyesight impairment 27.8 17.5 13.2 9.7 6.4 
Hearing impairment 28.3 21.4 19.2 12.3 14.0 
Smell impairment 14.7 13.3 10.7 9.9 8.3 
Taste impairment 10.1 8.5 6.2 6.1 4.0 
      
Unweighted N      
Men      
Eyesight impairment 455 519 621 677 733 
Hearing impairment 455 519 621 678 733 
Smell impairment 428 490 595 654 710 
Taste impairment 429 490 595 654 710 
Women      
Eyesight impairment 679 786 803 765 768 
Hearing impairment 680 786 804 765 767 
Smell impairment 655 764 789 744 741 
Taste impairment 655 764 789 744 741 
For variable definitions, see AH.13–AH.15, AH.18, AH.20 and AH.21. For related text, see H.9. 
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Table H5a. Mean walking speed (m/s), by age group and gender: wave 8 
 Age in 2016–17 All 
60–64 65–69 70–74 75–79 80+ 
Men 0.96 0.93 0.88 0.82 0.72 0.88 
Women 0.92 0.89 0.84 0.78 0.63 0.83 
       
Unweighted N      
 Men 494 586 557 396 356 2,389 
Women 647 799 598 468 517 3,029 
For variable definitions, see AH.2, AH.19 and AH.21. For related text, see H.10. 
 
Table H5b. Mean walking speed (m/s), by gender and wealth group: wave 8 
 Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men 0.74 0.83 0.88 0.92 0.98 
Women 0.69 0.78 0.83 0.88 0.94 
      
Unweighted N      
Men 302 375 507 551 617 
Women 458 588 662 625 653 
For variable definitions, see AH.18–AH.21. For related text, see H.11. 
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Table H6a. Limitations with one or more ADLs and IADLs (%),  
by age group and gender: wave 8 
  
  
Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
ADLs 8.4 13.1 14.6 18.0 19.9 37.1 17.0 
IADLs 7.7 14.3 15.4 17.8 25.2 40.6 18.3 
Women        
ADLs 11.2 15.0 15.5 18.5 18.5 36.2 18.8 
IADLs 12.9 18.1 17.8 22.2 28.6 52.1 24.5 
        
Unweighted N        
Men 231 576 659 624 459 517 3,066 
Women 316 726 888 680 535 759 3,904 
For variable definitions, see AH.1, AH.2 and AH.21. For related text, see H.12. 
 
Table H6b. Limitations with one or more ADLs and IADLs (%),  
by gender and wealth group: wave 8 
  
  
Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men      
ADLs 33.7 20.0 15.7 11.4 9.0 
IADLs 34.1 23.1 16.8 13.5 8.5 
Women      
ADLs 41.3 32.5 20.3 15.6 13.3 
IADLs 32.2 24.6 17.5 10.6 8.6 
 
     
Unweighted N      
Men 455 519 622 678 734 
Women 680 786 804 765 768 
For variable definitions, see AH.1, AH.18, AH.20 and AH.21. For related text, see H.13. 
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Table H7a. Mean cognitive function, by age group and gender: wave 8 
 Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
Memory 11.2 11.4 11.0 9.8 8.6 7.3 10.2 
Attention 6.1 6.0 6.0 5.9 5.7 5.6 5.9 
Comprehension 4.8 4.8 4.8 4.8 4.7 4.4 4.7 
Women        
Memory 12.3 12.2 11.8 10.7 9.6 7.4 10.8 
Attention 5.6 5.7 5.7 5.5 5.3 5.3 5.6 
Comprehension 4.8 4.8 4.8 4.8 4.6 4.3 4.7 
        
Unweighted N        
Men        
Memory 226 548 629 599 428 466 2,896 
Attention 213 531 604 575 404 422 2,749 
Comprehension 225 537 619 584 416 444 2,825 
Women        
Memory 306 710 864 661 514 687 3,742 
Attention 289 668 796 599 448 595 3,395 
Comprehension 300 695 854 643 494 659 3,645 
For variable definitions, see AH.2, AH.6–AH.8 and AH.21. For related text, see H.14. 
 
Table H7b. Mean cognitive function, by age group and gender: wave 8 
 Wealth group in 2016–17 
Lowest 2nd  3rd  4th  Highest 
Men      
Memory 8.6 9.7 9.8 10.9 11.5 
Attention 5.6 5.7 6.0 6.2 6.1 
Comprehension 4.4 4.8 4.7 4.8 4.9 
Women      
Memory 9.2 10.2 10.7 11.6 12.5 
Attention 5.0 5.4 5.5 5.8 6.0 
Comprehension 4.5 4.6 4.7 4.8 4.9 
      
Unweighted N      
Men      
Memory 426 488 587 649 703 
Attention 366 462 553 635 691 
Comprehension 406 470 571 642 694 
Women      
Memory 653 759 783 741 734 
Attention 545 695 704 693 697 
Comprehension 623 737 760 727 727 
For variable definitions, see AH.6–AH.8, AH.18, AH.20 and AH.21. For related text, see H.15.  
Health domain tables 
 
 
276 
Table H8a. Health behaviours (%) by age group and gender: wave 8 
 Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
Current smokers 11.7 15.3 9.7 10.1 8.2 2.3 10.1 
Physically inactive 8.0 11.4 11.6 14.5 23.5 39.8 16.2 
Daily alcohol consumption 14.6 24.9 26.5 29.0 23.8 24.4 23.4 
At least five portions of fruit 
and veg/day 
39.5 48.4 56.9 55.5 56.1 54.5 50.9 
Women        
Current smokers 14.4 14.2 11.6 9.1 7.1 3.9 10.4 
Physically inactive 11.3 13.7 16.3 22.5 26.4 51.1 22.8 
Daily alcohol consumption 13.5 15.0 14.1 15.7 13.1 13.7 14.2 
At least five portions of fruit 
and veg/day 
66.1 61.6 65.9 67.0 66.0 56.5 63.9 
        
Unweighted N        
Men        
Current smokers 231 576 657 623 459 516 3,062 
Physically inactive 231 574 659 623 458 516 3,061 
Daily alcohol consumption 197 487 597 547 399 406 2,633 
At least five portions of fruit 
and veg/day 
196 485 594 541 396 400 2,612 
Women        
Current smokers 316 726 888 679 535 759 3,903 
Physically inactive 316 721 887 679 534 759 3,896 
Daily alcohol consumption 263 655 803 614 466 566 3,367 
At least five portions of fruit 
and veg/day 
262 656 803 614 467 558 3,360 
For variable definitions, see AH.2, AH.3, AH.9, AH.12, AH.17 and AH.21.  
For related text, see H.16. 
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Table H8b. Health behaviours (%) by gender and wealth group: wave 8 
 
Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men      
Current smokers 26.8 10.2 8.0 4.5 4.5 
Physically inactive 37.4 19.5 15.4 8.7 6.3 
Daily alcohol consumption 17.9 20.4 18.6 23.4 32.1 
At least five portions of fruit 
and veg/day 
43.8 46.5 56.1 53.0 52.8 
Women      
Current smokers 19.3 11.7 10.2 5.4 4.6 
Physically inactive 43.4 30.6 19.6 12.6 8.0 
Daily alcohol consumption 6.5 9.8 12.8 16.6 23.8 
At least five portions of fruit 
and veg/day 
51.2 60.0 64.8 65.3 75.9 
 
     
Unweighted N      
Men      
Current smokers 455 519 621 675 734 
Physically inactive 453 519 622 677 732 
Daily alcohol consumption 346 423 536 618 673 
At least five portions of fruit 
and veg/day 
343 422 526 615 669 
Women      
Current smokers 679 786 804 765 768 
Physically inactive 677 784 803 763 768 
Daily alcohol consumption 537 667 717 700 695 
At least five portions of fruit 
and veg/day 
536 664 717 695 697 
For variable definitions, see AH.3, AH.9, AH.12, AH.17, AH.18, AH.20 and AH.21.  
For related text, see H.17. 
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Table HL1a. Fair or poor self-rated health (%), by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men 21.1 21.8 26.8 26.1 30.3 2,379 
50–54 19.7 17.8 22.7 22.7 27.0 272 
55–59 19.3 18.6 23.2 21.5 23.0 509 
60–64 22.6 23.8 26.8 24.8 28.8 591 
65–69 22.4 20.3 28.6 29.8 34.5 411 
70–74 21.1 24.6 30.2 29.4 34.6 353 
75–79 19.9 27.1 28.5 34.0 39.6 171 
80+ 27.0 32.5 43.8 35.9 50.0 72 
       
Women 23.4 24.9 26.8 28.6 29.7 3,019 
50–54 20.8 23.5 24.6 21.4 24.6 341 
55–59 20.9 19.9 21.3 23.1 22.7 660 
60–64 21.8 20.9 25.0 25.1 25.0 728 
65–69 25.4 23.2 24.5 28.3 29.2 507 
70–74 21.6 28.0 32.1 36.8 37.8 446 
75–79 29.3 36.3 35.6 40.8 46.4 214 
80+ 33.9 42.1 41.4 42.2 43.7 123 
For variable definitions, see AH.2, AH.5, AH.16 and AH.21. For related text, see H.19. 
 
Table HL1b. Fair or poor self-rated health (%), by gender and wealth: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men      2,330 
Lowest 46.1 45.8 53.1 49.9 53.4 300 
2nd  28.1 30.0 34.0 37.2 36.3 385 
3rd  16.5 16.6 23.3 22.7 29.3 456 
4th  16.9 16.2 19.7 20.1 24.5 537 
Highest 7.9 10.0 13.7 10.7 17.0 652 
       
Women      2,953 
Lowest 45.1 44.9 45.4 46.9 48.8 456 
2nd  28.6 29.8 33.4 32.4 35.0 554 
3rd  21.3 23.3 26.2 30.5 29.1 622 
4th  17.0 16.4 18.3 20.7 21.2 608 
Highest 8.8 13.6 14.0 15.7 17.5 713 
For variable definitions, see AH.5, AH.16, AH.18, AH.20 and AH.21. For related text, see H.20. 
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Table HL2a. Diagnosed CHD (%), by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men 10.9 16.9 17.8 19.2 20.6 2,484 
50–54 3.2 6.9 7.1 10.1 11.5 285 
55–59 7.0 10.2 11.2 12.3 13.6 535 
60–64 8.4 14.5 16.0 17.6 18.8 616 
65–69 14.1 22.5 23.6 24.7 25.8 425 
70–74 17.5 25.0 25.2 26.2 27.6 370 
75–79 23.5 30.0 30.4 31.7 32.3 173 
80+ 20.7 36.1 37.7 37.7 41.4 80 
       
Women 6.6 10.8 11.4 12.2 12.8 3,090 
50–54 0.6 2.2 2.9 3.3 3.5 349 
55–59 1.9 4.1 4.1 4.8 5.1 678 
60–64 4.4 7.5 7.9 9.2 9.9 744 
65–69 8.6 13.7 14.1 15.0 15.8 519 
70–74 9.6 17.0 19.1 20.1 21.2 453 
75–79 17.1 25.4 25.9 25.9 25.9 219 
80+ 17.8 23.4 25.8 26.9 27.6 128 
For variable definitions, see AH.2, AH.5, AH.10 and AH.21. For related text, see H.21. 
 
Table HL2b. Diagnosed CHD (%), by gender and wealth: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men      2,434 
Lowest 17.6 25.0 26.5 28.0 28.6 318 
2nd  9.0 16.7 17.8 19.1 21.0 403 
3rd  11.8 17.9 18.3 19.4 21.2 477 
4th  10.5 15.8 16.8 19.0 20.6 557 
Highest 7.4 11.5 12.3 13.3 14.1 679 
       
Women      3,024 
Lowest 11.0 17.3 18.3 19.5 20.2 463 
2nd  8.6 13.0 13.6 14.2 14.9 568 
3rd  6.8 11.4 12.2 13.3 14.2 635 
4th  3.8 7.6 8.0 8.5 8.8 626 
Highest 4.0 6.1 6.6 7.1 7.4 732 
For variable definitions, see AH.5, AH.10, AH.18, AH.20 and AH.21. For related text, see H.22. 
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Table HL3a. Diagnosed diabetes (%), by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men 10.2 12.5 14.4 16.3 17.7 2,483 
50–54 7.8 9.0 11.6 12.8 13.8 285 
55–59 7.0 10.7 12.7 15.0 16.5 535 
60–64 10.2 11.6 13.7 15.3 16.6 616 
65–69 13.1 15.4 17.5 19.9 20.7 425 
70–74 14.8 16.7 17.4 19.3 21.0 369 
75–79 13.4 15.9 17.5 18.3 19.5 173 
80+ 8.9 12.0 12.9 15.7 19.3 80 
       
Women 7.7 9.5 10.9 12.6 14.0 3,091 
50–54 4.8 6.1 7.8 8.9 10.9 349 
55–59 5.6 6.5 7.6 9.9 11.5 678 
60–64 8.2 10.1 11.4 12.5 13.8 745 
65–69 6.4 8.0 8.9 10.6 12.5 519 
70–74 10.5 13.7 14.5 16.2 17.1 453 
75–79 12.4 15.7 20.2 22.7 23.5 219 
80+ 11.3 12.5 12.5 13.3 14.8 128 
For variable definitions, see AH.2, AH.5, AH.10 and AH.21. For related text, see H.21. 
 
Table HL3b. Diagnosed diabetes (%), by gender and wealth: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men      2,433 
Lowest 13.4 18.3 21.0 22.7 24.6 318 
2nd  10.7 13.4 16.1 18.8 21.0 403 
3rd  10.3 12.3 12.9 15.0 15.8 477 
4th  9.7 10.8 12.8 14.9 15.5 556 
Highest 8.2 9.7 11.5 12.3 14.0 679 
       
Women      3,025 
Lowest 13.0 15.8 18.0 21.6 24.0 463 
2nd  9.6 12.0 13.4 15.7 17.2 568 
3rd  6.9 8.7 10.0 10.7 12.1 636 
4th  7.4 8.2 9.6 11.1 12.1 626 
Highest 2.9 4.4 5.2 6.0 7.2 732 
For variable definitions, see AH.5, AH.10, AH.18, AH.20 and AH.21. For related text, see H.22. 
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Table HL4a. Diagnosed cancer (%), by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted N 
Men 5.4 7.5 9.5 11.6 14.0 2,496 
50–54 4.0 4.3 6.3 6.5 7.4 287 
55–59 1.6 3.0 3.7 5.6 7.7 535 
60–64 4.4 7.0 8.1 9.6 12.1 618 
65–69 6.2 9.1 12.8 15.5 18.7 426 
70–74 11.1 14.8 18.1 23.7 26.9 374 
75–79 9.9 12.9 15.1 17.3 19.7 175 
80+ 11.8 12.5 17.1 17.9 20.0 81 
       
Women 8.6 10.3 11.7 13.8 16.0 3,115 
50–54 5.3 6.9 7.7 7.7 10.2 352 
55–59 7.4 8.6 10.5 13.3 15.3 679 
60–64 8.3 10.4 11.9 14.2 16.3 751 
65–69 11.3 13.4 14.5 16.8 18.2 521 
70–74 9.5 11.4 12.1 14.1 16.7 459 
75–79 6.8 8.6 10.3 13.1 13.6 222 
80+ 13.7 15.8 16.4 18.9 24.4 131 
For variable definitions, see AH.2, AH.5, AH.10 and AH.21. For related text, see H.23. 
 
Table HL4b. Diagnosed cancer (%), by gender and wealth: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men      2,446 
Lowest 6.2 7.8 12.0 14.6 15.4 318 
2nd  6.1 7.3 10.3 13.9 15.6 407 
3rd  5.3 7.1 8.2 10.2 12.5 479 
4th   4.2 6.6 7.5 8.7 11.7 560 
Highest 5.8 9.2 10.6 12.3 15.5 682 
       
Women      3,049 
Lowest 7.8 8.9 10.9 13.3 15.9 473 
2nd  8.1 9.7 10.5 12.0 14.1 569 
3rd  9.4 11.1 12.4 14.8 16.5 640 
4th  8.9 11.8 12.8 15.5 18.1 631 
Highest 8.1 9.9 11.2 13.2 15.3 736 
For variable definitions, see AH.5, AH.10, AH.18, AH.20 and AH.21. For related text, see H.24. 
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Table HL5a. Diagnosed depression (%), by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted N 
Men 7.7 8.9 9.5 10.2 10.5 2,502 
50–54 8.6 11.1 12.2 13.6 13.6 288 
55–59 10.2 11.6 11.7 12.5 13.0 537 
60–64 8.3 9.7 10.3 10.9 11.3 618 
65–69 8.2 9.4 10.7 11.4 11.5 427 
70–74 4.4 4.7 6.0 6.0 6.7 376 
75–79 0.7 0.7 0.7 0.7 0.7 175 
80+ 5.3 5.3 5.3 5.3 5.3 81 
       
Women 10.7 12.3 13.5 14.5 15.1 3,121 
50–54 10.9 14.2 17.2 20.0 20.8 353 
55–59 12.0 13.9 14.9 16.2 17.0 680 
60–64 14.4 15.7 17.1 17.4 18.1 752 
65–69 11.4 12.5 13.8 14.6 14.8 523 
70–74 7.2 7.8 8.6 9.1 9.5 460 
75–79 4.7 6.2 6.2 7.5 7.5 222 
80+ 6.9 7.8 7.8 8.9 8.9 131 
For variable definitions, see AH.2, AH.5, AH.10 and AH.21. For related text, see H.25. 
 
Table HL5b. Diagnosed depression (%), by gender and wealth: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men      2,452 
Lowest 13.1 15.4 16.0 17.2 18.1 319 
2nd  7.5 8.7 9.2 9.8 9.8 408 
3rd  6.8 7.8 9.3 10.0 10.4 479 
4th  6.9 7.9 8.6 8.8 9.1 562 
Highest 5.9 6.4 6.6 7.2 7.3 684 
       
Women      3,055 
Lowest 14.8 16.7 18.4 20.5 21.3 473 
2nd  11.6 13.4 15.4 16.6 16.7 570 
3rd  9.9 11.5 12.2 12.4 13.3 640 
4th  8.8 10.4 11.1 12.5 12.9 634 
Highest 8.9 9.6 10.6 11.2 11.7 738 
For variable definitions, see AH.5, AH.10, AH.18, AH.20 and AH.21. For related text, see H.26. 
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Table HL6a. Walking speed (mean, m/s), by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted N 
Men 0.99 0.98 0.97 0.92 0.87 1,203 
60–64 1.03 1.02 1.04 0.99 0.94 475 
65–69 1.01 1.00 0.98 0.94 0.88 327 
70–74 0.95 0.94 0.91 0.88 0.83 268 
75–79 0.89 0.89 0.85 0.77 0.72 120 
80+ 0.87 0.86 0.85 0.68 0.61 13 
       
Women 0.94 0.93 0.90 0.85 0.82 1,480 
60–64 1.00 0.99 0.97 0.92 0.90 578 
65–69 0.97 0.96 0.93 0.88 0.87 390 
70–74 0.91 0.88 0.84 0.79 0.74 336 
75–79 0.81 0.80 0.75 0.71 0.64 136 
80+ 0.75 0.73 0.63 0.58 0.54 40 
For variable definitions, see AH.2, AH.5, AH.19 and AH.21. For related text, see H.27. 
 
Table HL6b. Walking speed (mean, m/s), by gender and wealth: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted N 
Men      1,178 
Lowest 0.88 0.88 0.83 0.81 0.75 121 
2nd  0.92 0.93 0.89 0.85 0.80 159 
3rd  0.96 0.94 0.94 0.88 0.84 249 
4th  1.01 0.99 0.98 0.93 0.88 289 
Highest 1.08 1.06 1.07 1.02 0.95 360 
       
Women      1,448 
Lowest 0.82 0.80 0.76 0.72 0.70 177 
2nd  0.88 0.88 0.84 0.82 0.78 249 
3rd  0.94 0.92 0.89 0.83 0.79 325 
4th  0.96 0.95 0.92 0.88 0.86 314 
Highest 1.03 1.01 0.99 0.94 0.90 383 
For variable definitions, see AH.5 and AH.18–AH.21. For related text, see H.28. 
  
Health domain tables 
 
 
284 
Table HL7a. At least one difficulty with ADL (%), by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted N 
Men 14.3 14.4 15.9 17.2 20.3 2,500 
50–54 11.5 10.3 10.3 11.4 13.4 287 
55–59 9.7 11.9 12.5 12.0 15.7 536 
60–64 14.2 13.5 13.8 16.5 16.9 618 
65–69 14.6 15.5 14.7 16.2 19.1 427 
70–74 17.4 17.5 17.7 21.1 25.0 376 
75–79 22.6 20.5 26.3 27.3 32.9 175 
80+ 26.8 23.9 44.7 44.8 55.7 81 
       
Women 17.1 17.8 18.9 19.7 21.1 3,119 
50–54 14.0 14.0 15.1 16.0 15.8 353 
55–59 11.3 11.4 12.8 13.1 14.9 680 
60–64 14.1 12.5 15.0 15.2 17.4 751 
65–69 16.9 16.5 19.0 20.5 17.2 523 
70–74 19.8 23.5 24.6 23.0 25.1 460 
75–79 27.2 28.2 28.1 29.1 30.9 221 
80+ 36.0 42.9 38.0 44.5 54.6 131 
For variable definitions, see AH.1, AH.2, AH.5 and AH.21. For related text, see H.29. 
 
Table HL7b. At least one difficulty with ADL (%), by gender and wealth: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men      2,450 
Lowest 30.0 26.1 28.5 29.3 37.1 319 
2nd  14.8 17.9 17.0 17.9 23.1 407 
3rd  10.7 13.4 15.2 15.9 17.1 479 
4th  10.8 12.1 13.9 15.1 17.6 562 
Highest 9.9 7.3 9.4 11.3 12.1 683 
       
Women      3,053 
Lowest 35.4 33.5 31.9 34.9 35.2 473 
2nd  19.5 22.6 22.6 24.9 27.8 570 
3rd  15.4 15.9 19.2 18.3 19.4 640 
4th  10.5 11.1 13.8 13.2 14.5 632 
Highest 7.1 8.4 9.3 9.7 11.5 738 
For variable definitions, see AH.1, AH.5, AH.18, AH.20 and AH.21.  
For related text, see H.30. 
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Table HL8a. Mean memory score, by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted N 
Men 10.8 10.7 10.8 10.3 10.0 2,356 
50–54 11.5 11.7 11.8 11.6 11.6 271 
55–59 11.7 11.5 11.9 11.7 11.5 509 
60–64 11.2 11.1 11.3 10.8 10.6 582 
65–69 10.3 10.4 10.2 9.6 9.2 404 
70–74 9.8 9.5 9.6 8.9 8.5 351 
75–79 9.6 9.4 9.2 8.2 7.8 167 
80+ 8.5 8.3 8.2 6.8 6.3 72 
       
Women 11.5 11.4 11.4 11.0 10.8 2,989 
50–54 12.3 12.3 12.9 12.5 12.6 340 
55–59 12.2 12.3 12.5 12.2 12.2 658 
60–64 12.1 12.1 12.2 11.7 11.6 720 
65–69 11.2 11.1 10.9 10.7 10.4 502 
70–74 10.6 10.5 10.3 9.8 9.2 437 
75–79 9.6 9.5 9.1 8.1 7.7 212 
80+ 9.0 8.3 8.1 7.2 6.3 120 
For variable definitions, see AH.2, AH.5, AH.8 and AH.21. For related text, see H.31. 
 
Table HL8b. Mean memory score, by gender and wealth: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men      2,306 
Lowest 9.6 9.9 9.6 8.9 8.7 297 
2nd  10.2 10.0 10.3 9.8 9.4 384 
3rd  10.4 10.4 10.4 9.9 9.6 451 
4th  11.1 11.0 11.3 10.6 10.4 529 
Highest 11.6 11.5 11.5 11.2 11.0 645 
       
Women      2,924 
Lowest 10.2 10.2 10.1 9.4 9.3 453 
2nd  10.9 10.8 11.0 10.5 10.1 549 
3rd  11.3 11.3 11.3 10.9 10.7 618 
4th  11.9 11.9 11.9 11.5 11.2 599 
Highest 12.4 12.3 12.3 12.0 12.0 705 
For variable definitions, see AH.5, AH.8, AH.18, AH.20 and AH.21. For related text, see H.32. 
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Table HL9a. Current smoker (%), by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted N 
Men 14.5 13.4 12.2 10.9 9.9 2,445 
50–54 20.4 17.9 18.9 16.5 15.5 283 
55–59 18.9 18.1 16.0 14.5 12.1 524 
60–64 16.8 15.1 13.3 13.1 11.8 602 
65–69 11.5 10.7 9.5 7.1 7.5 421 
70–74 9.6 8.4 7.4 5.9 6.7 364 
75–79 3.9 4.0 3.0 3.5 2.4 174 
80+ 1.0 1.0 1.0 0.0 0.0 77 
       
Women 13.9 13.0 11.5 10.6 9.6 3,040 
50–54 23.2 21.9 20.9 17.6 16.4 346 
55–59 17.3 16.3 14.4 13.2 12.8 667 
60–64 14.7 12.7 12.0 11.1 9.6 731 
65–69 11.5 11.0 9.5 8.3 7.8 513 
70–74 8.6 7.6 6.8 6.5 5.3 439 
75–79 9.6 10.3 7.0 8.3 6.5 216 
80+ 3.6 3.6 1.8 2.9 1.8 128 
For variable definitions, see AH.2, AH.5, AH.17 and AH.21. For related text, see H.33. 
 
Table HL9b. Current smoker (%), by gender and wealth: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men      2,411 
Lowest 36.0 34.3 29.4 28.3 27.4 313 
2nd  14.9 13.0 11.3 8.4 7.7 401 
3rd  11.6 10.9 11.5 9.0 8.4 475 
4th  8.1 6.9 7.1 6.0 5.6 553 
Highest 7.2 6.5 5.5 6.1 4.2 669 
       
Women      2,975 
Lowest 24.2 23.7 21.6 20.6 18.6 456 
2nd  17.7 16.0 13.7 12.6 10.4 560 
3rd  14.6 13.3 12.0 10.4 10.0 627 
4th  7.7 7.2 5.8 5.4 5.3 612 
Highest 7.0 6.5 5.6 5.1 4.7 720 
For variable definitions, see AH.5, AH.17, AH.18, AH.20 and AH.21. For related text, see H.34. 
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Table HL10a. Daily alcohol consumer (%), by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted N 
Men 28.3 26.4 25.9 24.8 26.1 1,769 
50–54 24.9 20.7 20.3 16.9 19.1 186 
55–59 23.3 27.2 25.9 23.5 25.8 383 
60–64 33.1 31.9 30.5 31.0 30.5 449 
65–69 31.1 27.5 27.8 28.4 27.9 322 
70–74 26.5 21.1 23.4 20.6 21.7 269 
75–79 36.3 27.0 25.9 27.0 31.6 111 
80+ 25.7 18.3 18.1 19.8 23.0 49 
       
Women 17.5 16.9 16.2 14.5 14.9 2,253 
50–54 18.3 16.3 15.2 15.1 13.4 248 
55–59 16.4 18.1 17.4 15.1 15.9 503 
60–64 17.1 17.8 17.2 15.7 15.8 578 
65–69 18.3 16.6 17.9 14.7 14.7 401 
70–74 17.6 15.9 13.8 13.2 12.2 327 
75–79 19.4 16.1 15.6 15.7 17.0 128 
80+ 17.8 12.5 8.4 5.1 13.4 68 
For variable definitions, see AH.2, AH.3, AH.5 and AH.21. For related text, see H.35. 
 
Table HL10b. Daily alcohol consumer (%), by wealth and gender: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men      1,744 
Lowest 20.4 18.4 17.8 14.8 15.0 173 
2nd  20.6 19.1 18.8 18.7 22.3 263 
3rd  24.3 21.3 20.2 19.3 19.7 353 
4th  28.8 26.3 26.1 26.2 27.4 429 
Highest 38.6 38.2 37.9 35.9 36.7 526 
       
Women      2,207 
Lowest 8.1 7.6 7.6 6.3 6.8 274 
2nd   9.0 8.5 7.2 9.4 8.6 387 
3rd  14.1 12.9 11.3 10.6 10.0 487 
4th  21.2 18.8 18.3 15.2 16.6 468 
Highest 28.3 29.9 29.7 24.9 26.4 591 
For variable definitions, see AH.3, AH.5, AH.18, AH.20 and AH.21. For related text, see H.36. 
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Table HL11a. Physical inactivity (%), by age and gender: waves 4 to 8 
Age in 2008–09 Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted N 
Men 9.6 11.6 12.5 15.2 19.3 2,499 
50–54 5.5 9.0 8.4 11.9 10.1 287 
55–59 7.7 8.4 9.1 10.1 12.5 536 
60–64 10.0 11.3 11.4 14.2 14.7 617 
65–69 12.0 12.0 15.1 14.6 20.4 427 
70–74 11.3 15.0 13.8 19.1 26.5 376 
75–79 9.7 17.3 14.3 21.8 37.0 175 
80+ 18.8 19.2 33.9 39.8 56.3 81 
       
Women 17.7 17.4 19.9 22.9 26.3 3,113 
50–54 12.0 13.3 14.7 17.1 13.7 352 
55–59 13.9 10.7 13.2 13.1 16.5 679 
60–64 10.1 12.1 12.9 15.6 18.4 748 
65–69 16.6 15.9 18.8 20.3 25.0 523 
70–74 19.6 21.3 22.7 27.5 33.6 458 
75–79 33.0 34.7 34.6 43.6 47.4 222 
80+ 44.8 38.7 54.1 63.1 70.6 131 
For variable definitions, see AH.2, AH.5, AH.12 and AH.21. For related text, see H.37. 
 
Table HL11b. Physical inactivity (%), by wealth and gender: waves 4 to 8 
Wealth group 
2008–09 
Wave 4 Wave 5 Wave 6 Wave 7 Wave 8 Unwted 
N 
Men      2,449 
Lowest 21.2 29.1 26.6 32.8 36.6 319 
2nd  14.0 14.0 20.1 21.8 24.6 407 
3rd  7.1 8.3 9.1 13.0 16.7 479 
4th  5.0 7.1 6.3 9.6 13.5 561 
Highest 4.7 5.2 6.2 5.5 11.4 683 
       
Women      3,047 
Lowest 35.9 34.9 35.3 44.2 47.1 472 
2nd  21.1 24.1 27.8 27.7 33.3 567 
3rd  16.2 13.4 18.9 23.0 25.6 639 
4th  9.1 9.0 10.5 13.8 17.0 632 
Highest 9.3 8.3 9.5 9.4 12.0 737 
For variable definitions, see AH.5, AH.12, AH.18, AH.20 and AH.21. For related text, see H.38. 
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Table N1a. Mean body mass index (kg/m2), by age and gender: wave 8 
 Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men 28.3 28.4 29.2 28.2 28.3 27.2 28.3 
Women 28.7 28.6 28.8 28.1 28.0 26.7 28.2 
 
Unweighted N  
       
Men 174 256 298 279 216 266 1,489 
Women 239 308 397 311 254 343 1,852 
For variable definitions, see AH.21 and AH.25. For related text, see H.39. 
 
Table N1b. Body mass index categories (%), by age and gender: wave 8  
 Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
Underweight 0.6 0.3 0.7 0.4 0.6 0.5 0.5 
Desirable 18.9 24.2 16.3 25.4 22.8 30.0 22.3 
Overweight 55.3 40.7 44.8 41.8 46.7 48.5 46.5 
Obese 25.1 34.8 38.2 32.4 29.9 21.0 30.7 
Women        
Underweight 0.0 0.6 0.9 0.8 0.0 4.0 1.1 
Desirable 35.2 31.7 29.6 28.5 31.8 33.2 31.8 
Overweight 26.5 30.7 32.6 38.5 38.4 38.3 33.5 
Obese 38.4 36.9 36.9 32.3 29.8 24.5 33.7 
        
Unweighted N        
Men 173 256 298 278 216 266 1,487 
Women 238 307 397 311 253 341 1,847 
Note: Underweight indicates BMI < 18.5, desirable indicates BMI from 18.5 to 24.9, 
overweight indicates BMI from 25 to 29.9 and obese indicates BMI of 30 or more.  
For variable definitions, see AH.21 and AH.25. For related text, see H.39. 
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Table N1c. Body mass index (kg/m2) means, by wealth group and gender: wave 8 
 Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men 29.4 29.2 28.6 27.9 27.4 
Women 29.7 28.4 28.9 27.5 26.2 
      
Unweighted N      
Men 180 256 335 348 367 
Women 276 368 415 396 379 
For variable definitions, see AH.21 and AH.25. For related text, see H.40. 
 
Table N1d. Body mass index categories (%), by wealth group and gender: wave 8 
 Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men      
Underweight 1.6 0.3 0.3 0.6 0.0 
Desirable 20.9 20.6 16.8 22.7 27.5 
Overweight 30.4 39.2 54.4 52.9 49.9 
Obese 47.0 39.9 28.5 23.8 22.7 
Women      
Underweight 0.9 2.0 0.5 0.6 1.0 
Desirable 21.1 27.4 28.6 37.6 45.4 
Overweight 33.0 38.1 32.5 30.9 34.2 
Obese 45.0 32.5 38.4 30.9 19.5 
      
Unweighted N      
Men 180 256 335 348 365 
Women 276 368 414 394 377 
Note: Underweight indicates BMI < 18.5, desirable indicates BMI from 18.5 to 24.9, 
overweight indicates BMI from 25 to 29.9 and obese indicates BMI 30 or more. 
For variable definitions, see AH.21 and AH.25. For related text, see H.40. 
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Table N2a. Means of systolic and diastolic blood pressure (mmHg), by age and gender: 
wave 8 
 Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
Systolic BP  128.2 132.2 133.6 133.1 134.7 129.8 131.7 
Diastolic BP 78.9 75.8 74.5 71.9 69.5 64.3 73.4 
Women        
Systolic BP 125.0 129.0 131.0 133.3 135.0 134.5 130.8 
Diastolic BP 76.6 75.5 72.5 71.8 69.6 66.5 72.4 
        
Unweighted N        
Men 169 246 289 270 211 266 1,451 
Women  229 302 384 300 249 341 1,805 
For variable definitions, see AH.21 and AH.26. For related text, see H.41. 
 
 
Table N2b. Means of systolic and diastolic blood pressure (mmHg), by wealth group and 
gender: wave 8 
  Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men      
Mean Systolic BP 129.8 133.6 131.9 131.7 130.4 
Mean Diastolic BP 72.2 73.8 73.1 73.9 73.7 
Women      
Mean Systolic BP 131.8 131.0 132.3 129.7 128.1 
Mean Diastolic BP 72.2 71.6 72.9 72.9 72.3 
      
Unweighted N      
Men 162 248 333 351 355 
Women 268 268 268 268 268 
For variable definitions, see AH.21 and AH.26. For related text, see H.42. 
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Table N3a. Lipid profile (mmol/l), by age and gender: wave 8 
 Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
Mean total cholesterol 5.23 5.16 4.95 4.70 4.49 4.46 4.90 
% ≥ 5.0 mmol/l Chol 58.1 54.9 44.5 38.0 30.1 34.8 45.6 
Mean HDL cholesterol  1.34 1.43 1.47 1.47 1.44 1.38 1.42 
% < 1.0 mmol/l HDL 12.6 9.4 11.4 7.8 9.6 14.6 10.9 
Mean LDL cholesterol 3.16 3.07 2.88 2.78 2.59 – 2.94 
% ≥ 3.0 mmol/l LDL 56.3 52.5 43.2 41.0 37.3 – 47.4 
Mean triglyceridesa 1.88 1.44 1.54 1.32 1.37 – 1.55 
% ≥ 1.7 mmol/l Trig 44.8 30.3 31.6 18.7 25.0 – 31.8 
Women        
Mean total cholesterol 5.76 5.74 5.39 5.39 5.09 4.93 5.42 
% ≥ 5.0 mmol/l Chol 82.3 77.7 66.2 61.8 47.5 50.0 66.0 
Mean HDL cholesterol 1.79 1.76 1.72 1.67 1.75 1.72 1.74 
% < 1.2 mmol/l HDL 7.1 9.9 8.8 9.3 7.5 10.3 8.8 
Mean LDL cholesterol 3.35 3.40 3.10 3.17 2.76 – 3.19 
% ≥ 3.0 mmol/l LDL 65.5 67.6 56.4 55.7 35.8 – 58.3 
Mean triglyceridesa 1.44 1.38 1.36 1.43 1.31 – 1.39 
% ≥ 1.7 mmol/l Trig 26.8 25.1 23.3 29.1 18.9 – 25.1 
        
Unweighted N        
Men        
Total cholesterol 156 219 242 224 157 181 1,179 
HDL cholesterol 156 219 241 224 157 181 1,178 
LDL cholesterol 107 152 187 159 107 – 712 
Triglycerides 113 156 190 159 107 – 725 
Women        
Total cholesterol 211 259 335 249 204 221 1,479 
HDL cholesterol 211 259 336 249 204 221 1,480 
LDL cholesterol 148 201 263 193 144 – 949 
Triglycerides 149 202 266 193 144 – 954 
Note: Triglycerides and LDL cholesterol measurements were carried out on those who are 
eligible to fast according to the protocol. Chol indicates total cholesterol, HDL indicates HDL 
cholesterol, LDL indicates LDL cholesterol and Trig indicates triglycerides.  
aGeometric means are reported. 
For variable definitions, see AH.21 and AH.27. For related text, see H.43. 
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Table N3b. Lipid profile (mmol/l), by wealth group and gender: wave 8 
 Wealth group in 2016–17 
Lowest 2nd 3rd 4th Highest 
Men      
Mean total cholesterol 4.61 4.89 4.84 5.05 5.06 
% ≥ 5.0 mmol/l Chol 32.0 46.7 43.8 52.9 50.2 
Mean HDL cholesterol 1.28 1.36 1.41 1.46 1.53 
% < 1.0 mmol/l HDL 19.8 12.8 9.2 8.3 6.0 
Mean LDL cholesterol 2.76 2.89 2.89 3.03 3.01 
% ≥ 3.0 mmol/l LDL 35.6 40.7 44.4 57.8 49.5 
Mean triglyceridesa 1.8 1.8 1.5 1.5 1.3 
% ≥ 1.7 mmol/l Trig 51.5 41.4 34.9 26.1 21.0 
Women      
Mean total cholesterol 5.09 5.36 5.44 5.58 5.60 
% ≥ 5.0 mmol/l Chol 54.9 64.1 64.2 72.6 76.2 
Mean HDL cholesterol 1.61 1.71 1.70 1.83 1.90 
% < 1.2 mmol/l HDL 9.8 9.5 11.1 5.6 5.0 
Mean LDL cholesterol 3.05 3.10 3.26 3.28 3.23 
% ≥ 3.0 mmol/l LDL 56.1 54.7 56.8 63.5 61.2 
Mean triglyceridesa 1.5 1.5 1.5 1.2 1.1 
% ≥ 1.7 mmol/l Trig 33.8 25.8 29.9 21.2 10.2 
      
Unweighted N      
Men      
Total cholesterol 134 193 274 277 296 
HDL cholesterol 134 193 274 277 296 
LDL cholesterol 63 108 167 180 195 
Triglycerides 64 111 168 183 198 
Women      
Total cholesterol 210 286 331 332 309 
HDL cholesterol 210 286 331 332 309 
LDL cholesterol 113 190 205 223 214 
Triglycerides 113 191 207 223 215 
Note: Triglycerides and LDL cholesterol measurements were carried out on those who are 
eligible to fast according to the protocol. Chol indicates total cholesterol, HDL indicates HDL 
cholesterol, LDL indicates LDL cholesterol and Trig indicates triglycerides.  
aGeometric means are reported. 
For variable definitions, see AH.21 and AH.27. For related text, see H.44. 
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Table N4a. Fibrinogen (g/l) and C-reactive protein (mg/l) means,  
by age and gender: wave 8 
 Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
Mean fibrinogen 3.17 3.21 3.28 3.35 3.45 3.41 3.29 
Mean C-reactive proteina 1.16 1.00 1.26 1.26 1.39 1.62 1.23 
Women        
Mean fibrinogen 3.28 3.28 3.32 3.41 3.47 3.35 3.34 
Mean C-reactive proteina 1.36 1.44 1.38 1.44 1.48 1.52 1.43 
        
Unweighted N         
Fibrinogen        
Men 142 203 216 199 137 159 1,056 
Women 190 229 299 225 178 198 1,319 
C-reactive protein        
Men 151 210 235 210 147 165 1,118 
Women 197 249 319 241 199 211 1,416 
aGeometric means are reported. Participants with levels greater than 10 mg/l were 
excluded. 
For variable definitions, see AH.21 and AH.27. For related text, see H.45. 
 
 
Table N4b. Fibrinogen (g/l) and C-reactive protein (mg/l) means,  
by wealth group and gender: wave 8  
 
Wealth group in 2016–17 
Lowest  2nd  3rd  4th  Highest  
Men      
Mean fibrinogen 3.47 3.31 3.40 3.18 3.12 
Mean C-reactive proteina 1.81 1.35 1.34 1.12 0.90 
Women      
Mean fibrinogen 3.38 3.38 3.37 3.28 3.25 
Mean C-reactive proteina 1.88 1.45 1.49 1.25 1.13 
      
Unweighted N       
Fibrinogen      
Men 122 175 241 248 266 
Women 189 253 294 299 273 
C-reactive protein      
Men 122 179 260 265 289 
Women 199 275 318 313 299 
aGeometric means are reported. Participants with levels greater than 10 mg/l were 
excluded. 
For variable definitions, see AH.21 and AH.27. For related text, see H.46. 
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Table N5a. Glycated haemoglobin (%) means, by gender and age: wave 8 
 Age in 2016–17 All 
 55–59 60–64 65–69 70–74 75–79 80+ 
Men 5.69 5.68 5.76 5.89 5.84 5.96 5.78 
Women 5.72 5.75 5.76 5.80 5.91 5.78 5.78 
        
Unweighted N        
Men 153 219 242 221 157 184 1,176 
Women 208 262 333 247 202 225 1,477 
For variable definitions, see AH.21 and AH.27. For related text, see H.47. 
 
 
Table N5b. Glycated haemoglobin (%) means, by wealth group and gender: wave 8 
 Wealth group in 2016–17 
 Lowest 2nd 3rd 4th Highest 
Men 6.00 5.63 5.79 5.76 5.74 
Women 5.96 5.78 5.78 5.68 5.66 
      
Unweighted N      
Men 132 194 273 278 296 
Women 210 289 327 335 304 
For variable definitions, see AH.21 and AH.27. For related text, see H.48. 
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Table N6a. Mean haemoglobin (g/dl) and anaemia (%), by age and gender: wave 8 
  Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men        
Mean haemoglobin (g/dl) 15.3 14.9 14.9 14.8 14.2 13.6 14.7 
Anaemia (%) 1.1 3.5 3.3 5.8 21.5 28.3 8.5 
Women        
Mean haemoglobin (g/dl) 13.5 13.5 13.4 13.4 13.2 13.0 13.3 
Anaemia (%) 3.3 6.6 7.9 8.6 9.0 21.4 9.2 
        
Unweighted N        
Men 153 215 241 219 155 179 1,162 
Women 208 259 326 243 198 221 1,455 
Note: Anaemia defined as haemoglobin level below 13g/dl for men and  
below 12 g/dl for women. 
For variable definitions, see AH.21 and AH.27. For related text, see H.49. 
 
Table N6b. Mean haemoglobin (g/dl) and anaemia prevalence, by wealth group and 
gender: wave 8 
 Wealth group in 2016–17 
 Lowest 2nd 3rd 4th Highest 
Haemoglobin (g/dl)      
Men  14.7 14.8 14.7 14.8 14.7 
Women  13.0 13.4 13.5 13.4 13.4 
Anaemia (%)      
Men 9.8 8.7 11.5 5.4 6.7 
Women 17.8 7.8 7.8 6.3 5.2 
      
Unweighted N      
Men 131 188 270 275 295 
Women 209 279 325 331 299 
Note: Anaemia defined as haemoglobin level below 13g/dl for men and 
below 12 g/dl for women. 
For variable definitions, see AH.21 and AH.27. For related text, see H.50. 
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Table N7a. Mean levels of IGF-1 (nmol/l), by gender and age: wave 8 
 
Age in 2016–17 All 
55–59 60–64 65–69 70–74 75–79 80+ 
Men         
Mean IGF-1 17.5 16.3 15.8 15.2 14.6 12.9 15.7 
% in lowest quintile 10.8 18.3 27.2 32.8 31.1 48.7 26.0 
Women        
Mean IGF-1 14.7 14.4 13.4 13.4 12.9 11.8 13.5 
% in lowest quintile 16.7 16.2 23.4 23.0 31.3 42.4 24.7 
        
Unweighted N        
Men 155 218 241 224 156 181 1,175 
Women 211 258 335 249 204 221 1,478 
Note: Gender-specific quintiles used. 
For variable definitions, see AH.21 and AH.27. For related text, see H.51. 
 
Table N7b. Mean levels of IGF-1 (nmol/l), by wealth group and gender: wave 8 
 Wealth group in 2016–17 
 Lowest 2nd 3rd 4th Highest 
Men      
Mean IGF-1 14.93 15.40 15.72 16.19 16.10 
% in lowest quintile 34.3 27.9 25.1 24.3 18.8 
Women       
Mean IGF-1 12.80 13.34 13.53 14.08 13.86 
% in lowest quintile 30.8 24.9 26.3 20.6 21.3 
      
Unweighted N      
Men 134 192 272 278 295 
Women 210 285 330 332 309 
Note: Gender-specific quintiles used. 
For variable definitions, see AH.21 and AH.27. For related text, see H.52. 
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Table N8a. Mean levels of vitamin D (nmol/l), by gender and age: wave 8 
 Age in 2016–17 All 
 55–59 60–64 65–69 70–74 75–79 80+ 
Men 44.0 44.4 49.3 45.9 49.5 42.9 45.9 
Women 45.2 46.0 49.9 45.6 50.4 44.4 46.8 
        
Unweighted N        
Men 154 218 241 223 155 180 1,171 
Women 207 256 332 248 200 220 1,463 
For variable definitions, see AH.21 and AH.27. For related text, see H.53. 
 
Table N8b. Mean levels of vitamin D (nmol/l), by wealth group and gender: wave 8 
 Wealth group in 2016–17 
 Lowest 2nd 3rd 4th Highest 
Men 39.4 43.3 48.1 46.5 49.3 
Women 43.9 43.9 44.6 52.8 50.1 
      
Unweighted N      
Men 134 192 270 276 295 
Women 207 282 328 330 304 
For variable definitions, see AH.21 and AH.27. For related text, see H.54. 
 
 
Table N9a. Mean grip strength (kilograms), by gender and age: wave 8 
 Age in 2016–17 All 
 55–59 60–64 65–69 70–74 75–79 80+ 
Men 42 40 39 35 32 28 37 
Women 25 24 22 21 19 16 22 
        
Unweighted N        
Men 178 257 297 277 219 272 1,500 
Women 244 306 393 299 252 344 1,838 
For variable definitions, see AH.21 and AH.28. For related text, see H.55. 
 
Table N9b. Mean grip strength (kilograms), by wealth group and gender: wave 8 
 Wealth group in 2016–17 
 Lowest 2nd 3rd 4th Highest 
Men 34 37 37 38 40 
Women 20 21 22 23 24 
      
Unweighted N      
Men 176 257 343 354 367 
Women 266 362 422 395 376 
For variable definitions, see AH.21 and AH.28. For related text, see H.56. 
 
 
 
 
 
 
